230 related articles for article (PubMed ID: 19932771)
1. MMP-12 catalytic domain recognizes and cleaves at multiple sites in human skin collagen type I and type III.
Taddese S; Jung MC; Ihling C; Heinz A; Neubert RH; Schmelzer CE
Biochim Biophys Acta; 2010 Apr; 1804(4):731-9. PubMed ID: 19932771
[TBL] [Abstract][Full Text] [Related]
2. Conformational selection and collagenolysis in type III collagen.
Salsas-Escat R; Stultz CM
Proteins; 2010 Feb; 78(2):325-35. PubMed ID: 19731369
[TBL] [Abstract][Full Text] [Related]
3. Defining requirements for collagenase cleavage in collagen type III using a bacterial collagen system.
Yu Z; Visse R; Inouye M; Nagase H; Brodsky B
J Biol Chem; 2012 Jun; 287(27):22988-97. PubMed ID: 22573319
[TBL] [Abstract][Full Text] [Related]
4. Location of 3-hydroxyproline residues in collagen types I, II, III, and V/XI implies a role in fibril supramolecular assembly.
Weis MA; Hudson DM; Kim L; Scott M; Wu JJ; Eyre DR
J Biol Chem; 2010 Jan; 285(4):2580-90. PubMed ID: 19940144
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-1 cleavage site recognition and binding in full-length human type III collagen.
Williams KE; Olsen DR
Matrix Biol; 2009 Jul; 28(6):373-9. PubMed ID: 19398000
[TBL] [Abstract][Full Text] [Related]
6. Mapping of macrophage elastase cleavage sites in insoluble human skin elastin.
Taddese S; Weiss AS; Neubert RH; Schmelzer CE
Matrix Biol; 2008 Jun; 27(5):420-8. PubMed ID: 18334288
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Collagen Engineered to Bind to Discoidin Domain Receptor Functions as a Receptor Inhibitor.
An B; Abbonante V; Xu H; Gavriilidou D; Yoshizumi A; Bihan D; Farndale RW; Kaplan DL; Balduini A; Leitinger B; Brodsky B
J Biol Chem; 2016 Feb; 291(9):4343-55. PubMed ID: 26702058
[TBL] [Abstract][Full Text] [Related]
8. pH dependence of the enzymatic processing of collagen I by MMP-1 (fibroblast collagenase), MMP-2 (gelatinase A), and MMP-14 ectodomain.
Gioia M; Fasciglione GF; Monaco S; Iundusi R; Sbardella D; Marini S; Tarantino U; Coletta M
J Biol Inorg Chem; 2010 Nov; 15(8):1219-32. PubMed ID: 20549272
[TBL] [Abstract][Full Text] [Related]
9. Assembly of stable human type I and III collagen molecules from hydroxylated recombinant chains in the yeast Pichia pastoris. Effect of an engineered C-terminal oligomerization domain foldon.
Pakkanen O; Hämäläinen ER; Kivirikko KI; Myllyharju J
J Biol Chem; 2003 Aug; 278(34):32478-83. PubMed ID: 12805365
[TBL] [Abstract][Full Text] [Related]
10. The recognition of collagen and triple-helical toolkit peptides by MMP-13: sequence specificity for binding and cleavage.
Howes JM; Bihan D; Slatter DA; Hamaia SW; Packman LC; Knauper V; Visse R; Farndale RW
J Biol Chem; 2014 Aug; 289(35):24091-101. PubMed ID: 25008319
[TBL] [Abstract][Full Text] [Related]
11. Activity of matrix metalloproteinase-9 against native collagen types I and III.
Bigg HF; Rowan AD; Barker MD; Cawston TE
FEBS J; 2007 Mar; 274(5):1246-55. PubMed ID: 17298441
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of secreted and membrane-type matrix metalloproteinase activities based on substitutions and interruptions of triple-helical sequences.
Minond D; Lauer-Fields JL; Cudic M; Overall CM; Pei D; Brew K; Moss ML; Fields GB
Biochemistry; 2007 Mar; 46(12):3724-33. PubMed ID: 17338550
[TBL] [Abstract][Full Text] [Related]
13. Degradation of tropoelastin by matrix metalloproteinases--cleavage site specificities and release of matrikines.
Heinz A; Jung MC; Duca L; Sippl W; Taddese S; Ihling C; Rusciani A; Jahreis G; Weiss AS; Neubert RH; Schmelzer CE
FEBS J; 2010 Apr; 277(8):1939-56. PubMed ID: 20345904
[TBL] [Abstract][Full Text] [Related]
14. Xaa-Arg-Gly triplets in the collagen triple helix are dominant binding sites for the molecular chaperone HSP47.
Koide T; Takahara Y; Asada S; Nagata K
J Biol Chem; 2002 Feb; 277(8):6178-82. PubMed ID: 11751879
[TBL] [Abstract][Full Text] [Related]
15. Effects of flexibility of the α2 chain of type I collagen on collagenase cleavage.
Mekkat A; Poppleton E; An B; Visse R; Nagase H; Kaplan DL; Brodsky B; Lin YS
J Struct Biol; 2018 Sep; 203(3):247-254. PubMed ID: 29763735
[TBL] [Abstract][Full Text] [Related]
16. Site-specific quantitative analysis of overglycosylation of collagen in osteogenesis imperfecta using hydrazide chemistry and SILAC.
Taga Y; Kusubata M; Ogawa-Goto K; Hattori S
J Proteome Res; 2013 May; 12(5):2225-32. PubMed ID: 23581850
[TBL] [Abstract][Full Text] [Related]
17. In vitro degradation of human tropoelastin by MMP-12 and the generation of matrikines from domain 24.
Taddese S; Weiss AS; Jahreis G; Neubert RH; Schmelzer CE
Matrix Biol; 2009 Mar; 28(2):84-91. PubMed ID: 19144321
[TBL] [Abstract][Full Text] [Related]
18. Human fibronectin and MMP-2 collagen binding domains compete for collagen binding sites and modify cellular activation of MMP-2.
Steffensen B; Xu X; Martin PA; Zardeneta G
Matrix Biol; 2002 Aug; 21(5):399-414. PubMed ID: 12225805
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics simulation study on the interaction of collagen-like peptides with gelatinase-A (MMP-2).
Azhagiya Singam ER; Rajapandian V; Subramanian V
Biopolymers; 2014 Jul; 101(7):779-94. PubMed ID: 24374600
[TBL] [Abstract][Full Text] [Related]
20. The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity.
Minond D; Lauer-Fields JL; Cudic M; Overall CM; Pei D; Brew K; Visse R; Nagase H; Fields GB
J Biol Chem; 2006 Dec; 281(50):38302-13. PubMed ID: 17065155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
